Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
27.21
-0.43 (-1.56%)
At close: Dec 5, 2025, 4:00 PM EST
27.46
+0.25 (0.92%)
After-hours: Dec 5, 2025, 7:54 PM EST

Olema Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
-149.96-129.47-96.66-104.79-71.1-22.12
Upgrade
Depreciation & Amortization
0.420.390.380.360.160.01
Upgrade
Loss (Gain) From Sale of Assets
0.010.010.11---
Upgrade
Loss (Gain) From Sale of Investments
----0.28-
Upgrade
Stock-Based Compensation
19.6422.5817.2618.8315.913.11
Upgrade
Other Operating Activities
-5.6-7.03-4.230.511.220.64
Upgrade
Change in Accounts Payable
1.352.512.320.35-0.68-0.22
Upgrade
Change in Other Net Operating Assets
-0.536.65-2.912.673.51-1.29
Upgrade
Operating Cash Flow
-134.67-104.35-83.73-82.07-50.69-19.87
Upgrade
Capital Expenditures
--0.16--0.36-1.58-0.06
Upgrade
Sale of Property, Plant & Equipment
--0.01---
Upgrade
Investment in Securities
-108-93.37-4.8791.84-273.86-
Upgrade
Investing Cash Flow
-108-93.53-4.8591.48-275.44-0.06
Upgrade
Long-Term Debt Issued
-----3.09
Upgrade
Net Debt Issued (Repaid)
3----3.09
Upgrade
Issuance of Common Stock
252.06275.48133.420.481.39221.19
Upgrade
Other Financing Activities
-13.01-6.66----
Upgrade
Financing Cash Flow
242.05268.82133.420.481.39358.4
Upgrade
Net Cash Flow
-0.6370.9444.849.89-324.74338.48
Upgrade
Free Cash Flow
-134.67-104.51-83.73-82.43-52.27-19.92
Upgrade
Free Cash Flow Per Share
-1.62-1.78-1.85-2.06-1.32-2.84
Upgrade
Levered Free Cash Flow
-71.39-45.82-43.1-41.64-26.52-11.15
Upgrade
Unlevered Free Cash Flow
-71.39-45.82-43.1-41.64-26.52-10.74
Upgrade
Change in Working Capital
0.819.16-0.593.022.83-1.51
Upgrade
Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q